Jennifer McKimm-Breschkin

Jenny has a first class BSc Hons from Monash University, which started a life long career in trying to understand how viruses work, in order to control them.
She studied for her PhD working on measles virus at the Hershey Medical Center Microbiology Department, part of the Pennsylvania State University, as a Fulbright Fellow, under Dr Fred Rapp.
Returning to Australia as a QEII Postodoctoral Fellow, she worked at the Microbiology Department at Melbourne University on the newly discovered rotaviruses under Ian Holmes.
She spent 3 years as a Colin Syme Postdoctoral Fellow at the Walter and Eliza Hall Institute of Medical Research, under Jacques Miller trying to unravel the T cell receptor.
A position at the National Biological Standards Laboratories, working on Marek's Disease Virus, was followed by appointment to CSIRO to work on influenza virus where she has been since 1987. She was part of the team involved in the development of the world's first anti influenza drug, Relenza, and continues to work on understanding mechanisms of influenza resistance to Relenza and Tamiflu to help design next generation drugs.